AU2003249883A1 - Secreted polypeptide species associated with cardiovascular disorders - Google Patents

Secreted polypeptide species associated with cardiovascular disorders

Info

Publication number
AU2003249883A1
AU2003249883A1 AU2003249883A AU2003249883A AU2003249883A1 AU 2003249883 A1 AU2003249883 A1 AU 2003249883A1 AU 2003249883 A AU2003249883 A AU 2003249883A AU 2003249883 A AU2003249883 A AU 2003249883A AU 2003249883 A1 AU2003249883 A1 AU 2003249883A1
Authority
AU
Australia
Prior art keywords
cardiovascular disorders
secreted polypeptide
species associated
polypeptide species
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003249883A
Other languages
English (en)
Inventor
Lydie Bougueleret
Catherine Jeandenans
Bruno Pardo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genova Ltd
Original Assignee
Geneprot Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneprot Inc filed Critical Geneprot Inc
Publication of AU2003249883A1 publication Critical patent/AU2003249883A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AU2003249883A 2002-07-08 2003-06-26 Secreted polypeptide species associated with cardiovascular disorders Abandoned AU2003249883A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39457602P 2002-07-08 2002-07-08
US60/394,576 2002-07-08
US43866403P 2003-01-07 2003-01-07
US60/438,664 2003-01-07
PCT/EP2003/006766 WO2004005931A1 (en) 2002-07-08 2003-06-26 Secreted polypeptide species associated with cardiovascular disorders

Publications (1)

Publication Number Publication Date
AU2003249883A1 true AU2003249883A1 (en) 2004-01-23

Family

ID=30118429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003249883A Abandoned AU2003249883A1 (en) 2002-07-08 2003-06-26 Secreted polypeptide species associated with cardiovascular disorders

Country Status (5)

Country Link
US (1) US20070009955A1 (enExample)
EP (1) EP1521968A1 (enExample)
JP (1) JP2005533086A (enExample)
AU (1) AU2003249883A1 (enExample)
WO (1) WO2004005931A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1723432A1 (en) 2004-02-05 2006-11-22 Medtronic, Inc. Methods and apparatus for identifying patients at risk for life threatening arrhythmias
US7608458B2 (en) 2004-02-05 2009-10-27 Medtronic, Inc. Identifying patients at risk for life threatening arrhythmias
AU2005253081B2 (en) * 2004-06-03 2011-11-24 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for peripheral artery disease
US8335652B2 (en) 2004-06-23 2012-12-18 Yougene Corp. Self-improving identification method
US8027791B2 (en) 2004-06-23 2011-09-27 Medtronic, Inc. Self-improving classification system
WO2007069453A1 (ja) * 2005-12-14 2007-06-21 Eisai R & D Management Co., Ltd. 心電図ｑｔ時間延長作用の評価法
EP2405271A1 (en) * 2010-07-06 2012-01-11 Bio-Rad Innovations Markers of vulnerability of the atherosclerosis plaque
JP6068347B2 (ja) * 2010-10-20 2017-01-25 ルプレクト−カールズ−ウニベルシタット ハイデルベルク 筋機能を増強させる短ペプチド
US11531010B2 (en) * 2017-07-24 2022-12-20 Shimadzu Corporation Ion suppressor and ion chromatograph
TW202028222A (zh) * 2018-11-14 2020-08-01 美商Ionis製藥公司 Foxp3表現之調節劑

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888742A (en) * 1997-10-28 1999-03-30 Incyte Pharmaceuticals, Inc. Human phospholipid binding proteins
ATE440951T1 (de) * 1997-12-17 2009-09-15 Serono Genetics Inst Sa Verlängerte cdns, die für sekretierte proteine kodieren
DE19915485A1 (de) * 1999-04-07 2000-10-19 Hugo A Katus Therapie der Herzinsuffizienz
ATE378601T1 (de) * 1999-07-04 2007-11-15 Cardiovascular Res Inst Of Maa Diagnostischer test für menschlisches matrix gla- protein und seine verwendung als biomarker
GB0021497D0 (en) * 2000-09-01 2000-10-18 Novartis Res Foundation Compounds and their use

Also Published As

Publication number Publication date
US20070009955A1 (en) 2007-01-11
EP1521968A1 (en) 2005-04-13
WO2004005931A1 (en) 2004-01-15
JP2005533086A (ja) 2005-11-04

Similar Documents

Publication Publication Date Title
AU2003290316A1 (en) Curing
AU2003249883A1 (en) Secreted polypeptide species associated with cardiovascular disorders
AU2003211112A8 (en) Secreted proteins
GB0218977D0 (en) Polypeptide
AU2003222189A1 (en) Secreted proteins
AU2003214391A1 (en) Recombinant spores
AU2003246644A1 (en) Secreted peptides
HK1088949A (en) Secreted polypeptide species associated with cardiovascular disorders
HK1091262A (en) Secreted polypeptide species associated with cardiovascular disorders
HK1090651A (en) Secreted polypeptide species associated with cardiovascular disorders
HK1090120A (en) Secreted polypeptide species associated with cardiovascular disorders
HK1088946A (en) Secreted polypeptide species associated with cardiovascular disorders
AU2003254001A1 (en) Novel htnfsf13b protein variants
AU2003248933A1 (en) Secreted proteins
GB0223193D0 (en) Polypeptide
HK1087776A (en) Secreted polypeptide species reduced cardiovascular disorders
AU2003260997A1 (en) High-seal spout assembly
HK1092869A (en) Secreted polypeptide species reduced in cardiovascular disorders
HK1090063A (en) Secreted polypeptide species reduced in cardiovascular disorders
AU2003286581A1 (en) Secreted proteins
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003211532A1 (en) Novel polypeptide
GB0208925D0 (en) Polypeptide
AU2003265868A1 (en) Secreted proteins
AU2003205825A1 (en) Polypeptide variants

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase